Leaflet VISIPAQUE 320mg I/ml 320mgl / ml solution for injection

Indicated for: diagnostic imaging contrast enhancement

Route of administration: injectable

Substance: iodixanol (contrast agent)

ATC: V08AB09 (Various | X-ray contrast media, iodinated | Watersoluble, nephrotropic, low osmolar x-ray contrast media)

Precautions:
Anaphylaxis
Anaphylaxis

Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.

Additional monitoring
Additional monitoring

This medicine is subject to additional monitoring.

Nephrotoxicity
Nephrotoxicity

This medicine may affect the kidneys.

Iodixanol is an iodinated contrast agent used in medical imaging, particularly in computed tomography (CT) and angiography. It is a non-ionic, iso-osmolar compound that enhances the visualization of internal body structures by increasing the contrast between tissues.

The medication is administered intravenously or intra-arterially under the supervision of a specialist.

Side effects may include nausea, vomiting, a warm sensation, or allergic reactions. In rare cases, kidney dysfunction or anaphylactic reactions may occur.

Patients should inform their doctor about any allergies or kidney conditions before administration. Pregnant or breastfeeding women should consult a specialist before use.

General data about VISIPAQUE 320mg I/ml 320mgl / ml

  • Substance: iodixanol
  • Date of latest medicines list: 01-06-2026
  • Product code: W12013006
  • Concentration: 320mgl / ml
  • Pharmaceutical form: solution for injection
  • Packing volume: 100 ml
  • Product type: Original
  • Price: 1183.34 RON
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

  • Manufacturer: GE HEALTHCARE AS - NORVEGIA
  • Holder: GE HEALTHCARE AS - NORVEGIA
  • Number: 2482/2010/06
  • Shelf life: 3 years

Concentrations available for iodixanol

  • 150mgI/ml
  • 270mgI/ml
  • 320mgl/ml